'FabiSpray': Glenmark Launches Nitric Oxide Nasal Spray For Treatment Of Adult COVID-19 Patients
After DCGI's Nod, Glenmark Launches Anti-Viral Drug FabiFlu For Treatment Of Mild To Moderate Covid-19 Patients
Glenmark To Begin Phase 3 Clinical Trial On Combo Of Two Antiviral Drugs In Moderate Covid-19 Patients
